Nasdaq-Listed Canton Strategic Completes Sale of Gravitas Life Sciences on July 17

CC-0.16%
According to PRNewswire, Nasdaq-listed Canton Strategic Holdings completed the sale of its biotech research unit Gravitas Life Sciences to Gravitas Collective Corp on July 17, 2026. The transaction was unanimously approved by the company's board. Following the divestment, Canton Strategic will focus on its Canton Network platform to advance asset tokenization, financial market digitalization, and financial infrastructure services.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments